
ISO 22442:2007
ISO 22442:2007 Medical devices utilizing animal tissues and their derivatives – Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
CDN $233.00
Description
ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.
Edition
1
Published Date
2007-11-27
Status
PUBLISHED
Pages
22
Format 
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment
Abstract
ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-

ISO 10993:2017 Biological evaluation of medical devices – Part 11: Tests for systemic toxicity
CDN $273.00 Add to cart -

ISO 22442:2020 Medical devices utilizing animal tissues and their derivatives – Part 1: Application of risk management
CDN $233.00 Add to cart -

ISO 10993:2017 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
CDN $351.00 Add to cart -

ISO 10993:2020 Biological evaluation of medical devices – Part 18: Chemical characterization of medical device materials within a risk management process
CDN $413.00 Add to cart







